Anti-TCR antibody molecules and uses thereof

The disclosure provides antibody molecules that bind to TCR Vβ regions and multispecific molecules comprising said antibody molecules. Additionally, disclosed are nucleic acids encoding the same, methods of producing the aforesaid molecules, pharmaceutical compositions comprising aforesaid molecules...

Full description

Saved in:
Bibliographic Details
Main Authors HSU, Jonathan, VASH, Brian Edward, LOEW, Andreas, TAN, Seng-Lai
Format Patent
LanguageEnglish
Published 16.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The disclosure provides antibody molecules that bind to TCR Vβ regions and multispecific molecules comprising said antibody molecules. Additionally, disclosed are nucleic acids encoding the same, methods of producing the aforesaid molecules, pharmaceutical compositions comprising aforesaid molecules, and methods of treating an infectious disease using the aforesaid molecules.
AbstractList The disclosure provides antibody molecules that bind to TCR Vβ regions and multispecific molecules comprising said antibody molecules. Additionally, disclosed are nucleic acids encoding the same, methods of producing the aforesaid molecules, pharmaceutical compositions comprising aforesaid molecules, and methods of treating an infectious disease using the aforesaid molecules.
Author TAN, Seng-Lai
LOEW, Andreas
HSU, Jonathan
VASH, Brian Edward
Author_xml – fullname: HSU, Jonathan
– fullname: VASH, Brian Edward
– fullname: LOEW, Andreas
– fullname: TAN, Seng-Lai
BookMark eNrjYmDJy89L5WTQccwrydQNcQ5SSAQykvJTKhVy83NSk0tzUouBQikKpcVARklGalFqfhoPA2taYk5xKi-U5mZQdnMNcfbQTS3Ij08tLkhMTs1LLYl3DDUyAEIjM0sDE0dDY-JUAQDzpyvc
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2020226904A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2020226904A13
IEDL.DBID EVB
IngestDate Fri Aug 30 05:42:37 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2020226904A13
Notes Application Number: AU20200226904
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210916&DB=EPODOC&CC=AU&NR=2020226904A1
ParticipantIDs epo_espacenet_AU2020226904A1
PublicationCentury 2000
PublicationDate 20210916
PublicationDateYYYYMMDD 2021-09-16
PublicationDate_xml – month: 09
  year: 2021
  text: 20210916
  day: 16
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies MARENGO THERAPEUTICS, INC
RelatedCompanies_xml – name: MARENGO THERAPEUTICS, INC
Score 3.3611605
Snippet The disclosure provides antibody molecules that bind to TCR Vβ regions and multispecific molecules comprising said antibody molecules. Additionally, disclosed...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Anti-TCR antibody molecules and uses thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210916&DB=EPODOC&locale=&CC=AU&NR=2020226904A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUlMSQK2RI11jcyNknRNLJKNdROTzZJ1LS1MUi0N0tKMgRi02sLPzCPUxCvCNIKJIQe2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHRqBjLs3UXJxsXQP8Xfyd1ZydgT1JNb8gkBywtgJ2BU0cgX0lVlBDGnTSvmuYE2hfSgFypeImyMAWADQvr0SIgSk1T5iB0xl295owA4cvdMobyITmvmIRBh3HvJJM3RDnIAVgcGQm5adUKuRCbrdNLQYKpSiUFgMZoBZdan6aKIOym2uIs4cu0Np4uC_jHUOR3WgsxsAC7P-nSjAoGKQZJAMrVhNzY6M0YHcmzSLNwjjVLDEtyTgFGJaJFpIMMvhMksIvLc3ABQo30BIIQzMZBpaSotJUWWA9W5IkBw4eAOP8gBU
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQWlTxZrE9vuYUjXrlTdujE62dvoRwIFbYftEP97L7XTPe0hcCRwSQ4ud7_kcgdwS8MkQk-UKJqhRQo1Y6KEsR4rXZOyrso5wSaiLXzdm9GX-eO8Ae_rvzBVntCvKjkialSM-l5W5_Xy_xLLqWIri_soxa78yQ16jlyjY02kudRlp98bTMbO2JZtG5Gk7E_FGForhILUQqy0YwhKOE9vffEvZblpVNwD2J0gv6w8hAbL2tCy17XX2rA3qp-8kay1rziCOysrUyWwpxKKI43y5Fv6-K1uywrsSqRVgYTw6FjOj-HGHQS2p-C0i79dLqzZ5hrJCTQR_7NTkFSuxmhYqUE0jnCGm9wkTA95RBKUZWieQWcbp_Ptw9fQ8oLRcDF89l8vYF_IUIRDPOgdaJafK3aJNreMripR_QAHM4MA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Anti-TCR+antibody+molecules+and+uses+thereof&rft.inventor=HSU%2C+Jonathan&rft.inventor=VASH%2C+Brian+Edward&rft.inventor=LOEW%2C+Andreas&rft.inventor=TAN%2C+Seng-Lai&rft.date=2021-09-16&rft.externalDBID=A1&rft.externalDocID=AU2020226904A1